1-2 of 2
Luděk Pour
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials

Open Access
Clinical Trials & Observations
María-Victoria Mateos, Suzanne Trudel, Hang Quach, Paweł Robak, Meral Beksac, Ludek Pour, Marek Hus, Kihyun Kim, Vera Zherebtsova, Sosana Delimpasi, Tomas Jelínek, Christopher Ward, P. Joy Ho, Vladimir Vorobyev, Marcelo Pitombeira de Lacerda, Gracia Aparecida-Martinez, Ivan Spicka, Jakub Radocha, Michele Cavo, Claudio Cerchione, Chengcheng Fu, Kazuhito Suzuki, Rachel Rogers, Amy Phillips-Jones, Zhaohui Wang, Hena Baig, Jodie Wilkes, Xiaoou L. Zhou, Eric Lewis, Lydia Eccersley, Neal Sule, Prani Paka, Joanna B. Opalinska, Pralay Mukhopadhyay, Vania Hungria, Meletios Athanasios Dimopoulos
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5708–5719.
https://doi.org/10.1182/bloodadvances.2025016949
Published: 2025
Includes: Supplemental data
Journal Articles

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine

Free
Martina Zátopková, Tereza Ševčíková, Viola Fanfani, Zuzana Chyra, Lucie Říhová, Renata Bezděková, David Žihala, Kateřina Growková, Jana Filipová, Lucie Černá, Lucie Broskevičova, Fedor Kryukov, Jiří Minařík, Jana Smejkalová, Vladimír Maisnar, Ĺubica Harvanová, Luděk Pour, Alexandra Jungova, Tereza Popková, Juli Rodriguez Bago, Anjana Anilkumar Sithara, Matouš Hrdinka, Tomáš Jelínek, Michal Šimíček, Giovanni Stracquadanio, Roman Hájek
Journal: Blood Advances
Blood Adv (2022) 6 (2): 368–372.
https://doi.org/10.1182/bloodadvances.2020003876
Published: 2022
Includes: Supplemental data